Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on June 1, 2026 by admin

Downplaying toxicities in cancer drug trials is not acceptable

Nature Medicine, Published online: 01 June 2026; doi:10.1038/s41591-026-04463-x

As a physician I want to treat the patient, not just the tumor.

CategoriesUncategorized TagsMedication, News Approved

Post navigation

Previous PostPrevious Incretin therapies, nutrition and food insecurity in the UK
Next PostNext Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.